Lexeo Therapeutics, Inc. (LXEO) Misses Q1 EPS by 10c

Lexeo Therapeutics, Inc. (NASDAQ: LXEO) reported Q1 EPS of ($0.99), $0.10 worse than the analyst estimate of ($0.89).

For earnings history and earnings-related data on Lexeo Therapeutics, Inc. (LXEO) click here.

You May Also Be Interested In

• SolarEdge (SEDG) PT Lowered to $31 at Jefferies, 'We see shares as an unappealing short, not a compelling long'
• Trump says to rename Lake Ontario to Lake America
• HealthEquity (HQY) Tops Q2 EPS by 5c ; Offers Guidance